Our corporate social responsibility programmes
In India, we strive to work with our partners to address selected national health priorities in line with select UN Sustainable Development Goals (SDGs) and work towards supporting meritorious albeit financially constrained students pursue their education in Medicine, elimination of lymphatic filariasis; contribute towards Swachh Bharat and Swachh Vidyalaya (school sanitation) initiatives; and focus on child nutrition under the National Urban Health Mission (NUHM). In doing so, we are helping communities across the country.
In FY 2021-22, our CSR support extended to:
GSK Scholars programme
In India, we enable access to medical education for meritorious, financially constrained students.
The GSK Scholars programme, our flagship CSR initiative, is focussed towards providing scholarship of up to INR 1,00,000 per year for four- and a half years, to meritorious and financially constrained students to help them cover academic expenses incurred towards their MBBS programme.
The initiative aims to build India’s skill-building initiative and advance STEM education in the country. More than 117 students were felicitated into the first ever batch of the GSK Scholars programme.
Partnering India to eliminate Lymphatic Filariasis (LF)
In January 2012, we joined other global pharmaceutical companies and leading organisations, including the World Health Organisation (WHO) and the World Bank, in a united effort to support countries to defeat Neglected Tropical Diseases (NTDs).
In India, we have been donating albendazole tablets, used during mass drug administration (MDA) to the World Health Organization.
In order to interrupt transmission, districts in which lymphatic filariasis is endemic must be mapped and a strategy of preventive treatment called MDA implemented to treat the entire at-risk population. We have donated around 3 billion albendazole tablets to the WHO for distribution in affected areas and have pledged to donate albendazole for as long as needed to help eliminate LF as a public health issue from the country.
Health and hygiene
Swachh Bharat: Swachh Vidyalaya is the national campaign driving 'Clean India: Clean Schools'. A key feature of the campaign is to ensure that every school in India has a set of functioning and well-maintained water, sanitation and hygiene (WASH) facilities.
We have been supporting water, sanitation and hygiene (WASH) initiatives across 20 municipal schools in Nashik, Maharashtra, to help inculcate health and hygiene behaviours.
Mother and child health
The National Urban Health Mission (NUHM) proposes to address the healthcare needs of the rapidly growing urban population, with a focus on the disadvantaged and vulnerable sections.
We have been working for the upliftment of vulnerable communities within Mumbai, Maharashtra, and Naya Basti district, West Bengal, to improve the health and nourishment of children and their mothers.
We are also working with partners to improve the nutritional status of married women at pre- and post-conception and after delivery and of children aged 0-6 years in vulnerable communities.
Employee volunteering
At GSK, we strive to strengthen communities and bring the change that we wish to see in this world through volunteering. In 2021, we contributed over 5,200 volunteering hours towards various social causes.
ANNUAL CSR REPORT 2020-21
As a responsible corporate citizen, GSK continues to work tirelessly with its partners and stakeholders to address the needs of millions of people without access to basic healthcare in India. Through our CSR programmes, we strive to address identified national priorities, improve access and support people in vulnerable communities.
ANNUAL CSR REPORT 2019-20
In FY 19-20, GSK donated 32 million Albendazole tablets to the World Health Organisation to support MDA efforts across the country.
ANNUAL CSR REPORT 2018-19
We strive to work towards elimination of lymphatic filariasis; contribute towards Swachh Bharat; Swachh Vidyalaya (school sanitation); support 'Skill India' and focus on child nutrition.
